Abstract
The Ewing's family of tumors (EFT) comprises a molecularly defined group of ''small round blue cell tumors'', consisting of Ewing's sarcoma of bone (ESB), extraosseous Ewing's sarcoma (EES), peripheral primitive neuroectodermal tumor (pPNET), and Askin's tumor. Characteristic translocations that disrupt the EWSR1 gene located at 22q12 create novel fusion genes that are central to the pathogenesis. The EFT also shares certain clinical characteristics, such as a peak incidence during the teenage years, a tendency to spread rapidly, and responsiveness to the same chemotherapeutic regimens and radiation therapy. Nearly all patients have occult disseminated disease at diagnosis; hence, chemotherapy is routinely used. Improvements in multimodality treatment have had a dramatic impact on outcomes. EES/pPNET has been reported in a variety of sites, including the pancreas, though this is extremely rare. We describe a case of pancreatic EES/ pPNET in a 35-year-old woman and provide a brief review of the relevant literature.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 399-406 |
| Number of pages | 8 |
| Journal | International Journal of Clinical Oncology |
| Volume | 17 |
| Issue number | 4 |
| DOIs | |
| State | Published - Aug 2012 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Ewing's sarcoma
- Extraosseous Ewing's sarcoma
- PNET
- Pancreas
- Primitive neuroectodermal tumor
Fingerprint
Dive into the research topics of 'Extraosseous Ewing's sarcoma of the pancreas'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS